Gara Jalqabaatti › Colitis Ulcerative › Illinois › Chicago
Qorannoo klinikaalii Colitis Ulcerative Chicago, IL keessatti
Qorannoo 15 Colitis Ulcerative f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Namoota walitti qabaa jiraSadarkaa 2
- Northwestern University, Chicago
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Namoota walitti qabaa jiraSadarkaa 3
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Namoota walitti qabaa jiraSadarkaa 2
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Namoota walitti qabaa jiraSadarkaa 2
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Namoota walitti qabaa jiraSadarkaa 3
- Rush University Medical Center, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Namoota walitti qabaa jiraSadarkaa 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Namoota walitti qabaa jiraSadarkaa 2
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Namoota walitti qabaa jiraSadarkaa 2
- Northwestern University, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Namoota walitti qabaa jiraSadarkaa 4
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Namoota walitti qabaa jiraSadarkaa 3
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Namoota walitti qabaa jira
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Namoota walitti qabaa jiraQorannoo ilaalaa
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Namoota walitti qabaa jiraSadarkaa 2
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
Namoota walitti qabaa jiraSadarkaa 2
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Namoota walitti qabaa jira
- University of Chicago, Chicago
Qorannoo Colitis Ulcerative magaalota biroo keessatti
- New York City, NYQorannoo 23
- Orlando, FLQorannoo 22
- Miami, FLQorannoo 21
- Houston, TXQorannoo 17
- San Antonio, TXQorannoo 16
- Tyler, TXQorannoo 15
- Tacoma, WAQorannoo 15
- San Diego, CAQorannoo 15
- Colorado Springs, COQorannoo 14
- St. Louis, MOQorannoo 13
- Los Angeles, CAQorannoo 13
- Washington, DCQorannoo 12
Qorannoo biroo Chicago keessatti
- Kansara Qara'a Non-Small CellQorannoo 61
- Saree OljooQorannoo 59
- Saree (Gosoota Hunda)Qorannoo 51
- Kansara MetastatikiiQorannoo 45
- Kansarii ProstateQorannoo 45
- Dhibee QaraQorannoo 41
- ObesityQorannoo 41
- Kansarii OvariiQorannoo 36
- Kansarii ColorectalQorannoo 34
- StrokeQorannoo 34
- Cufama OnneeQorannoo 31
- Baayyee UlfaataaQorannoo 29
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.